Abstract: In an embodiment, a scannable storage element includes an input circuit for providing a first signal at first node based on a data input and a scan input, where the scan input is of pull-up logic in functional mode. The input circuit includes a first pull-up path comprising a switch receiving data input and a switch receiving scan enable input, and second pull-up path comprising a switch receiving scan input, first pull-down path comprising a switch receiving the scan enable input and a switch receiving the scan input, and second pull-down path comprising a switch receiving the data input. The storage element includes a shifting circuit configured to provide a second signal in response to the first signal at second node, and a scan output buffer coupled to the second node and configured to provide a scan output at a scan output terminal in response to the second signal.

Abstract: In an embodiment, a scannable storage element includes an input circuit for providing a first signal at first node based on a data input and a scan input, where the scan input is of pull-up logic in functional mode. The input circuit includes a first pull-up path comprising a switch receiving data input and a switch receiving scan enable input, and second pull-up path comprising a switch receiving scan input, first pull-down path comprising a switch receiving the scan enable input and a switch receiving the scan input, and second pull-down path comprising a switch receiving the data input. The storage element includes a shifting circuit configured to provide a second signal in response to the first signal at second node, and a scan output buffer coupled to the second node and configured to provide a scan output at a scan output terminal in response to the second signal.

Abstract: A scannable storage circuit includes a scan enable input, a storage element having a Node coupled to a data output buffer for driving a data output terminal. The data output buffer includes an inverter; a transmission gate having a first MOS transistor and a second MOS transistor with sources and drains coupled to each other, drains coupled to an output of the inverter and sources coupled to the data output terminal and gates coupled to the scan enable input and an inverted scan enable input. A third MOS transistor and a fourth MOS transistor is coupled to the sources of the first and second MOS transistors, the third MOS transistor and fourth MOS transistor are configured to pull up or pull down the data output terminal in response to a first control signal and a second control signal respectively. A scan output is generated from the output of the inverter.

Abstract: A scannable storage circuit includes a scan enable input, a storage element having a Node coupled to a data output buffer for driving a data output terminal. The data output buffer includes an inverter; a transmission gate having a first MOS transistor and a second MOS transistor with sources and drains coupled to each other, drains coupled to an output of the inverter and sources coupled to the data output terminal and gates coupled to the scan enable input and an inverted scan enable input. A third MOS transistor and a fourth MOS transistor is coupled to the sources of the first and second MOS transistors, the third MOS transistor and fourth MOS transistor are configured to pull up or pull down the data output terminal in response to a first control signal and a second control signal respectively. A scan output is generated from the output of the inverter.

Abstract: In one aspect, the present invention features a method of administering an active ingredient, said method comprising chewing an oral dosage form comprising a texture masked particle, said texture masked particle comprising a) a core containing an active ingredient; b) a first coating layer comprised of a taste masking agent that substantially covers the core, wherein said taste masking agent is comprised of an insoluble film forming polymer and a non-enteric, water soluble polymer; and c) a second coating layer on the surface of the first coating layer.

Abstract: In one embodiment, a dosage form comprises: (a) at least one active ingredient; (b) a molded core which is solid at room temperature; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment of this invention, a dosage form comprises: (a) at least one active ingredient; (b) a molded core comprising a plurality of particles; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium.

Abstract: A dosage form comprises: (a) a core comprising at least one active ingredient; and (b) a molded shell which surrounds the core, wherein the shell provides a predetermined time delay of greater than one hour for the onset of dissolution of the active ingredient upon contacting of the dosage form with a liquid medium and the delay is independent of the pH of the liquid medium. The weight of the shell may be at least 50 percent of the weight of the core, and the shell may have a thickness of about 500-4000 microns, or be substantially free of pores having a diameter of 0.5 to 5 microns.

Abstract: In one embodiment, a dosage form comprises: (a) at least one active ingredient; (b) a molded core which is solid at room temperature; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment of this invention, a dosage form comprises: (a) at least one active ingredient; (b) a molded core comprising a plurality of particles; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium.

Abstract: A dosage form comprises: (a) at least one active ingredient; (b) a core; and(c) a shell which surrounds the core, wherein the shell is substantially free of pores having a diameter of 0.5-5.0 microns, and the shell comprises a first shell portion and a second shell portion which are compositionally different and the dosage form provides a modified release profile of the active ingredient upon contacting of the dosage form with a liquid medium.

Abstract: A dosage form comprises:

Abstract: A dosage form comprises: (a) at least one active ingredient; (b) a core having an outer surface; and (c) a shell which resides upon at least a portion of the core outer surface, wherein at least a portion of the shell is semipermeable, such that the liquid medium diffuses through the semipermeable shell or shell portion to the core due to osmosis. The shell also provides for delivery of the active ingredient to a liquid medium outside the shell after contacting of the dosage form with the liquid medium. The dosage form delivers one or more active ingredients in a controlled manner upon contacting of the dosage form with a liquid medium. The dosage form may be employed to provide a burst release of the active ingredient, or to provide release of the active ingredient at an ascending release rate over an extended time period upon contacting of the dosage form with a liquid medium.

Abstract: An edible solid composition comprises: (a) about 25 to about 40 weight percent of at least one non-aqueous carrier material which has a melting temperature less than about 45 degrees C.; and (b) about 15 to about 60 weight percent of at least one thermoplastic material which has a melting temperature greater than about 50 degrees C. The composition may optionally additionally contain up to about 40 weight percent of at least one compatibility material for retaining the non-aqueous carrier material in the edible solid composition. The compatibility material is selected from the group consisting of emulsifiers, acrylic polymers, waxes and combinations thereof. The edible solid composition may be used as a core or shell in a dosage form, or as a dosage form per se which contains or is prepared from such an edible solid composition.

Abstract: Texture masked particles and chewable tablets made therefrom are disclosed. The texture masked particles are comprised of a core containing an active ingredient, an optional first coating layer comprised of a taste masking agent that substantially covers the core; and a second coating layer, which optionally may substantially cover the first coating layer or the core, comprised of a film forming polymer and a anti-grit agent. The particles may be produced into a tablet form, such as a chewable tablet form, that provides for the immediate release of the active ingredient.